Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Nat Prod Res ; 21(3): 274-81, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17365719

ABSTRACT

Both chronic venous insufficiency (CVI) and fatty liver may develop at the same time. Hesperidin and diosmin are used for the treatment CVI. There is no information, however, on the effect of these flavonoids in the redox state of fatty liver. In this study, male Wistar albino rats were fed a lipid-rich diet with or without 450 mg diosmin-50 mg hesperidin-containing drug (60 mg kg(-1) body weight/day, per os) for 9 days to determine the impact of treatment on antioxidant defence system of the fatty liver. We detected free SH-group concentration (SHC), hydrogen-donating ability (HDA), and natural scavenger capacity were decreased and hepatic malonaldehyde content and dien conjugate (DC) content in rats with fatty liver were increased compared to the control. After treatment in fatty liver, these parameters (except DC) significantly improved and approached the control value. Our results indicate that diosmin-hesperidin-containing drug may be a useful agent in improving the antioxidant defensive system in alimentary-induced fatty liver disease.


Subject(s)
Citrus/chemistry , Fatty Liver/chemically induced , Fatty Liver/metabolism , Flavonoids/pharmacology , Alanine Transaminase/blood , Alkaline Phosphatase/metabolism , Animals , Aspartate Aminotransferases/blood , Cholesterol/metabolism , Cholesterol, HDL/metabolism , Diet , Dietary Fats , Fatty Liver/pathology , Hepatocytes/pathology , Homeostasis/drug effects , L-Lactate Dehydrogenase/metabolism , Liver Function Tests , Male , Oxidation-Reduction , Oxidative Stress/drug effects , Rats , Rats, Wistar , Triglycerides/metabolism
2.
Clin Hemorheol Microcirc ; 36(1): 13-23, 2007.
Article in English | MEDLINE | ID: mdl-17211058

ABSTRACT

BACKGROUND: Conflicting results were reported about the efficacy of vitamin E (E) treatment in porphyria cutanea tarda (PCT). We conducted a study in PCT patients to investigate whether E treatment has any additional beneficial effects compared with phlebotomy (P) treatment alone on rheological and oxidative stress parameters. METHODS: Twenty three patients with sporadic PCT in clinical remission and 10 healthy control patients were studied. All patients were treated with P prior to the study until clinical remission was achieved. Baseline routine laboratory [blood glucose, serum lipids, C-reactive protein (CRP), iron metabolism indices, liver function tests], oxidative stress [serum thiobarbituric acid reactive substances (TBARS), plasma H-donor activity, plasma free SH-groups, erythrocyte glutathion peroxidase activity] and rheological parameters (whole blood and plasma viscosity, cell transit time, clogging rate) were measured in both groups. Then all PCT patients received E (tocopherol acetate) 200 mg/day for 8 weeks and at the end of treatment measurements identical to those performed at baseline were repeated. RESULTS: Increased urine uroporphyrin, serum CRP, TBARS concentrations, whole blood and plasma viscosity and decreased plasma H-donor activity, free SH-group level, erythrocyte glutathione peroxidase activity were detected in PCT patients treated with P alone compared with control group consistent with residual oxidative stress in PCT patients. E treatment decreased urine uroporphyrin and serum TBARS concentrations; increased plasma H-donor activity and did not influence whole blood and plasma viscosity compared with P treatment alone. CONCLUSIONS: E treatment reduced the residual oxidative stress and did not influence increased plasma and whole blood viscosity present in PCT patients receiving P treatment prior to clinical remission.


Subject(s)
Antioxidants/therapeutic use , Hemorheology/drug effects , Phlebotomy , Porphyria Cutanea Tarda/therapy , Vitamin E/therapeutic use , Adult , Aged , Aged, 80 and over , Alanine Transaminase/blood , Antioxidants/administration & dosage , Antioxidants/pharmacology , Aspartate Aminotransferases/blood , Blood Glucose/analysis , Blood Viscosity/drug effects , C-Reactive Protein/analysis , Erythrocyte Deformability/drug effects , Feces/chemistry , Female , Ferritins/blood , Glutathione Peroxidase/blood , Homeostasis/drug effects , Humans , Lipids/blood , Male , Middle Aged , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Porphyria Cutanea Tarda/blood , Porphyria Cutanea Tarda/drug therapy , Porphyria Cutanea Tarda/urine , Porphyrins/blood , Thiobarbituric Acid Reactive Substances/analysis , Uroporphyrins/urine , Vitamin A/blood , Vitamin E/administration & dosage , Vitamin E/blood , Vitamin E/pharmacology , gamma-Glutamyltransferase/blood
3.
J Agric Food Chem ; 53(1): 17-21, 2005 Jan 12.
Article in English | MEDLINE | ID: mdl-15631502

ABSTRACT

Antioxidant properties of marjoram (Origanum majorana L.) herb and extracts obtained with ethanol, n-hexane, and supercritical CO2 extraction are presented. Individual antioxidants, ursolic acid, carnosic acid, and carnosol, were quantified with high-performance liquid chromatography. The effects of different parameters (temperature and pressure) of high-pressure extraction on the yield of carnosol were studied. Furthermore, two marjoram herbs from Hungary and Egypt were compared measuring hydrogen-donating abilities with 1,1-diphenyl-2-picrylhydrazyl by spectrophotometric and the total scavenger capacities by chemiluminometric methods from the aqueous extracts of the herbs. The antioxidant activities of the solvent extracts were performed using the Rancimat method. The Egyptian herb and its extracts possessed better antioxidant activities than Hungarian ones. Applying supercritical CO2 extraction, the highest value of carnosol was obtained at 400 bar and 60 degrees C.


Subject(s)
Antioxidants/analysis , Origanum/chemistry , Phenols/analysis , Plant Leaves/chemistry , Triterpenes/analysis , Chromatography, Supercritical Fluid , Egypt , Hungary , Plant Extracts/chemistry , Solvents
4.
Nutrition ; 19(10): 869-75, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14559323

ABSTRACT

OBJECTIVE: Chinese Beiqishen tea was studied in an in vitro test system. METHODS: Phytochemical screening, trace element analysis, and the analysis of antioxidant properties were carried out. Characteristic constituents were determined by chromatographic (capillary gas chromatography and GCQ Ion Trap mass spectrometry) and spectrometric (ultraviolet and UV-VIS) methods. Element concentrations were determined by inductively coupled plasma optical emission spectrometry. Antioxidant capacity was studied by spectrophotometric and luminometric techniques using a Berthold Lumat 9501 luminometer. Hydrogen-donating activity, reducing power, and total scavenger capacity were measured. RESULTS: Total polyphenol content was 20.77 +/- 0.52 g/100 g of drug; total flavonoid content was 0.485 +/- 0.036 g/100 g of drug; and tannin content was 9.063 +/- 0.782 g/100 g of drug. Caffeine content was 1.08 mg/100 g of drug. Essential oils were identified by gas chromatography: (+)-limonene (21%), p-cymene (1.7%), estragol (3.2%), beta-ocimene (1.4%), and thymol (2.6%). Metallic ion analysis showed significantly high concentrations of Al, As, Ba, Cr, Cu, Fe, Mn, Ni, and Ti in the drug. Antioxidant and scavenger properties were identified as a function of concentration. CONCLUSIONS: The tea infusion contained some non-desirable trace elements and caffeine in addition to polyphenols and tannins in high concentrations. Therefore, the consumption of this tea may involve risks.


Subject(s)
Antioxidants/analysis , Beverages/analysis , Plant Extracts/analysis , Trace Elements/analysis , Alkaloids/analysis , Astragalus Plant/chemistry , Caffeine/analysis , Flavonoids/analysis , Food Analysis , Lycium/chemistry , Oils, Volatile/analysis , Phenols/analysis , Polyphenols , Reishi/chemistry , Tannins/analysis , Tea/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...